Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4536697 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4537238 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL180040 | 1.00 | — | — | |
| SCHEMBL4529894 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4533125 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4532638 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4538832 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4529900 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4528548 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4526908 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503523-B2 | Catalyst composition for polymerization of α-olefin and preparation and use thereof | PETROCHINA COMPANY LIMITED (CN) | 2025-12-23 | — | — | US | claimed |
| CN-115212922-B | Catalyst composition for alpha-olefin polymerization and preparation and application thereof | 中国石油天然气股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-117924573-A | 8B lubricating oil base oil and preparation method thereof | 中国石油天然气股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117924572-A | 8B lubricating oil base oil and preparation method thereof | 中国石油天然气股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-115216343-B | Preparation method of low-viscosity poly alpha-olefin synthetic oil | 中国石油天然气股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20230374169-A1 | CATALYST COMPOSITION FOR POLYMERIZATION OF a-OLEFIN AND PREPARATION AND USE THEREOF | PETROCHINA COMPANY LIMITED (CN) | 2023-11-23 | — | — | US | claimed |
| CN-114507339-B | Preparation method of vanillin-based polyester | 南昌大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115505001-A | Degradable micromolecular biquaternary ammonium salt with high antibacterial activity, degradation product thereof, and synthesis and degradation methods thereof | 中国人民大学 | 2022-12-23 | — | — | CN | claimed |
| CN-115216343-A | Preparation method of low-viscosity poly-alpha-olefin synthetic oil | 中国石油天然气股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-115212922-A | Catalyst composition for alpha-olefin polymerization and preparation and application thereof | 中国石油天然气股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| WO-2022217985-A1 | α-OLEFIN POLYMERIZED CATALYST COMPOSITION, PREPARATION THEREFOR AND USE THEREOF | 中国石油天然气股份有限公司 | 2022-10-20 | — | — | WO | claimed |
| CN-114507339-A | Preparation method of vanillin-based polyester | 南昌大学 | 2022-05-17 | — | — | CN | claimed |
| US-12503523-B2 | Catalyst composition for polymerization of α-olefin and preparation and use thereof | PETROCHINA COMPANY LIMITED (CN) | 2025-12-23 | — | — | US | disclosed |
| CN-115212922-B | Catalyst composition for alpha-olefin polymerization and preparation and application thereof | 中国石油天然气股份有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-115160123-B | Method for preparing carboxylic acid compound by oxidizing alcohol by using oxygen as oxidant under catalysis of copper | 复旦大学 | 2024-07-30 | — | — | CN | disclosed |
| CN-117924572-A | 8B lubricating oil base oil and preparation method thereof | 中国石油天然气股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2005003090-A1 | 1- (ALKYLAMINOALKYL-PYROLIDIN-/PIPERIDINYL) -2, 2-DIPHENYLACETAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | THERAVANCE, INC. (US) | 2005-01-13 | — | — | WO | disclosed |
| US-20040254219-A1 | Substituted pyrrolidine and related compounds | THERAVANCE BIOPHARMA R&D IP, LLC | 2004-12-16 | — | — | US | disclosed |
| US-20040122014-A1 | Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects | THERAVANCE BIOPHARMA R&D IP, LLC | 2004-06-24 | — | — | US | disclosed |
| WO-2004041806-A2 | SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS | THERAVANCE, INC. (US) | 2004-05-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122014-A1 | Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects | CHRM2, CHRM1, CHRM3 | LMNA 4783/4885ALDH1A1 1429/4885TSHR 296/4885 |
| US-20040254219-A1 | Substituted pyrrolidine and related compounds | CHRM1, CHRM5, ADRA1D | LMNA 4114/4885ALDH1A1 436/4885TSHR 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.